Solid Biosciences, Inc. (SLDB)
10.13
+0.41
(+4.22%)
USD |
NASDAQ |
Aug 27, 16:00
10.13
0.00 (0.00%)
After-Hours: 16:47
Solid Biosciences Shareholders Equity (Quarterly) : 374.08M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 374.08M |
| March 31, 2026 | 374.13M |
| December 31, 2025 | 180.01M |
| September 30, 2025 | 217.95M |
| June 30, 2025 | 258.29M |
| March 31, 2025 | 294.46M |
| December 31, 2024 | 137.25M |
| September 30, 2024 | 167.02M |
| June 30, 2024 | 193.24M |
| March 31, 2024 | 210.72M |
| December 31, 2023 | 126.48M |
| September 30, 2023 | 144.36M |
| June 30, 2023 | 163.73M |
| March 31, 2023 | 183.79M |
| December 31, 2022 | 211.67M |
| September 30, 2022 | 143.28M |
| June 30, 2022 | 162.24M |
| March 31, 2022 | 185.51M |
| December 31, 2021 | 208.21M |
| September 30, 2021 | 223.36M |
| Date | Value |
|---|---|
| June 30, 2021 | 237.94M |
| March 31, 2021 | 253.00M |
| December 31, 2020 | 132.09M |
| September 30, 2020 | 22.23M |
| June 30, 2020 | 40.71M |
| March 31, 2020 | 56.46M |
| December 31, 2019 | 80.05M |
| September 30, 2019 | 108.52M |
| June 30, 2019 | 76.50M |
| March 31, 2019 | 99.11M |
| December 31, 2018 | 125.18M |
| September 30, 2018 | 145.07M |
| June 30, 2018 | 162.29M |
| March 31, 2018 | 178.95M |
| December 31, 2017 | 64.92M |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | 47.14M |
| December 31, 2016 | -12.71M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Agenus, Inc. | -199.08M |
| Amgen, Inc. | 11.69B |
| Anika Therapeutics, Inc. | 137.28M |
| BioCryst Pharmaceuticals, Inc. | -454.29M |
| Imunon, Inc. | 4.189M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 420.58M |
| Total Liabilities (Quarterly) | 46.50M |
| Debt to Equity Ratio | 0.0539 |
| Current Ratio | 13.82 |
| Net Debt Paydown Yield | 0.07% |